AMAN U BUZDAR's research topics

AMAN U BUZDAR

Concepts (755)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Aromatase Inhibitors	79	2021	311	9.980	Why?
Breast Neoplasms	540	2022	16242	9.110	Why?
Antineoplastic Agents, Hormonal	91	2020	841	8.800	Why?
Triazoles	84	2014	629	8.300	Why?
Nitriles	84	2014	938	7.990	Why?
Tamoxifen	110	2013	875	7.050	Why?
Postmenopause	67	2020	365	3.490	Why?
Antineoplastic Combined Chemotherapy Protocols	208	2022	16740	3.100	Why?
Enzyme Inhibitors	36	2004	1944	2.980	Why?
Neoplasms, Hormone-Dependent	36	2012	347	2.900	Why?
Chemotherapy, Adjuvant	114	2019	4007	2.680	Why?
Estrogen Antagonists	24	2013	188	2.530	Why?
Androstadienes	18	2013	172	2.280	Why?
Estradiol	20	2021	828	2.270	Why?
Paclitaxel	57	2019	2114	2.270	Why?
Receptor, ErbB-2	39	2019	2657	2.020	Why?
Neoadjuvant Therapy	63	2022	5246	1.980	Why?
Antineoplastic Agents	99	2016	14638	1.870	Why?
Receptors, Estrogen	65	2019	2176	1.770	Why?
Doxorubicin	134	2017	3145	1.710	Why?
Fluorouracil	108	2019	1990	1.580	Why?
Estrogen Receptor Modulators	11	2011	110	1.570	Why?
Cyclophosphamide	114	2019	3245	1.420	Why?
Female	512	2022	148834	1.390	Why?
Clinical Trials as Topic	83	2017	3840	1.370	Why?
Antineoplastic Agents, Phytogenic	24	2013	898	1.270	Why?
Selective Estrogen Receptor Modulators	7	2013	128	1.190	Why?
Humans	566	2022	270637	1.070	Why?
Receptors, Progesterone	20	2017	1610	0.980	Why?
Disease-Free Survival	79	2018	10268	0.970	Why?
Epirubicin	12	2019	159	0.970	Why?
Neoplasm Recurrence, Local	66	2021	10404	0.950	Why?
Middle Aged	354	2021	90495	0.930	Why?
Neoplasm Metastasis	114	2018	5332	0.900	Why?
Mastectomy	44	2014	1554	0.840	Why?
Trastuzumab	20	2019	743	0.810	Why?
Carcinoma, Intraductal, Noninfiltrating	11	2014	690	0.810	Why?
Anthracyclines	9	2016	339	0.790	Why?
Aged	261	2019	73579	0.760	Why?
Megestrol Acetate	10	2004	30	0.760	Why?
Drug Administration Schedule	50	2019	3534	0.740	Why?
Adult	276	2021	82023	0.720	Why?
Anticarcinogenic Agents	3	2013	368	0.700	Why?
Antibodies, Monoclonal	20	2011	4468	0.670	Why?
Thiophenes	3	2007	147	0.650	Why?
Carcinoma	27	2006	2610	0.650	Why?
Taxoids	16	2013	1019	0.640	Why?
Breast Neoplasms, Male	9	2005	231	0.620	Why?
Double-Blind Method	25	2011	2570	0.600	Why?
Neoplasm Staging	83	2016	14033	0.600	Why?
Lymphatic Metastasis	56	2014	4969	0.600	Why?
Treatment Outcome	93	2018	33840	0.580	Why?
Antibiotics, Antineoplastic	15	2005	741	0.570	Why?
Combined Modality Therapy	74	2012	9053	0.570	Why?
Biomarkers, Tumor	23	2019	10725	0.540	Why?
Aromatase	6	2020	56	0.530	Why?
Survival Analysis	55	2016	9278	0.520	Why?
Piperidines	4	2007	1098	0.510	Why?
Time Factors	58	2019	12974	0.500	Why?
Megestrol	5	1998	15	0.490	Why?
Follow-Up Studies	73	2016	15274	0.480	Why?
Antibodies, Monoclonal, Humanized	19	2013	3427	0.480	Why?
Randomized Controlled Trials as Topic	25	2012	2656	0.460	Why?
Goserelin	2	2012	18	0.450	Why?
Prognosis	94	2017	22527	0.410	Why?
Survival Rate	47	2017	12528	0.410	Why?
Joint Diseases	2	2009	71	0.390	Why?
Premenopause	8	2013	135	0.390	Why?
Lymph Nodes	21	2014	3081	0.390	Why?
Vinblastine	20	2003	462	0.380	Why?
Dose-Response Relationship, Drug	30	2011	5053	0.360	Why?
Angiogenesis Inhibitors	3	2012	1270	0.330	Why?
Drug Resistance, Neoplasm	18	2020	5417	0.330	Why?
Niacinamide	1	2011	428	0.330	Why?
Mastectomy, Segmental	14	2011	1050	0.330	Why?
Aminoglutethimide	7	2001	13	0.330	Why?
BCG Vaccine	27	1986	429	0.320	Why?
Drug Delivery Systems	1	2013	663	0.320	Why?
Biological Therapy	1	2009	57	0.310	Why?
Neoplasms, Second Primary	7	2016	1388	0.310	Why?
Tubulin Modulators	1	2008	65	0.300	Why?
Epothilones	1	2008	55	0.300	Why?
Carcinoma, Ductal, Breast	9	2014	1235	0.300	Why?
Mammography	6	2013	1055	0.300	Why?
Aged, 80 and over	42	2016	31110	0.290	Why?
Vascular Endothelial Growth Factor A	2	2011	1580	0.290	Why?
Deoxycytidine	5	2018	1389	0.290	Why?
Gene Amplification	3	2006	764	0.280	Why?
Endometrium	3	2005	457	0.280	Why?
Puerto Rico	2	2019	63	0.270	Why?
Fadrozole	4	2001	8	0.270	Why?
Polymorphism, Single Nucleotide	8	2021	4643	0.270	Why?
Retrospective Studies	67	2022	39954	0.270	Why?
Medical Oncology	4	2013	1464	0.270	Why?
Prospective Studies	39	2017	13406	0.260	Why?
Diet, Fat-Restricted	1	2006	50	0.260	Why?
Cardiovascular Diseases	2	2011	2213	0.260	Why?
DNA Topoisomerases, Type II	1	2006	125	0.260	Why?
Drug Therapy, Combination	44	2006	2343	0.260	Why?
Quinazolines	3	2016	956	0.250	Why?
Indoles	1	2011	1028	0.250	Why?
Gonadotropin-Releasing Hormone	4	2001	168	0.250	Why?
ErbB Receptors	3	2007	2376	0.250	Why?
Estrone	4	2021	32	0.240	Why?
Drug Tolerance	7	2006	123	0.240	Why?
Mitomycins	9	1992	52	0.240	Why?
Evidence-Based Medicine	4	2011	1027	0.230	Why?
Neoplasm Invasiveness	8	2006	4054	0.230	Why?
Hormone Antagonists	1	2004	115	0.230	Why?
Risk Factors	24	2019	17849	0.230	Why?
Obesity	5	2016	2888	0.230	Why?
Kaplan-Meier Estimate	9	2018	6255	0.230	Why?
Proportional Hazards Models	20	2016	5093	0.230	Why?
Disease Progression	12	2019	6880	0.220	Why?
Multicenter Studies as Topic	6	2008	565	0.220	Why?
Adenocarcinoma	11	2001	7920	0.220	Why?
United States	21	2019	15813	0.210	Why?
Neoplasm, Residual	10	2017	1761	0.210	Why?
Methotrexate	26	2003	1025	0.210	Why?
Antimetabolites, Antineoplastic	5	2004	1347	0.200	Why?
Capecitabine	4	2012	391	0.200	Why?
Toremifene	2	1998	8	0.190	Why?
Patient Selection	12	2017	2029	0.190	Why?
Drug Design	1	2004	371	0.190	Why?
Ki-67 Antigen	5	2013	676	0.190	Why?
Nausea	9	2001	537	0.180	Why?
Risk Assessment	13	2017	6765	0.180	Why?
Axilla	17	2007	945	0.180	Why?
Decision Support Techniques	1	2005	603	0.180	Why?
Estrogens	6	2014	804	0.180	Why?
Forecasting	5	2007	699	0.180	Why?
Vomiting	8	2001	359	0.170	Why?
Pregnancy Complications, Neoplastic	3	2004	235	0.170	Why?
Guanidines	3	1995	61	0.170	Why?
Adjuvants, Pharmaceutic	1	1999	20	0.170	Why?
Antigens, Neoplasm	1	2006	1581	0.160	Why?
Remission Induction	15	2008	3658	0.160	Why?
Age Factors	16	2016	5436	0.160	Why?
Alkaline Phosphatase	2	2019	213	0.160	Why?
Epistasis, Genetic	1	2019	120	0.160	Why?
Heart Failure	10	2011	2330	0.150	Why?
DNA-Binding Proteins	2	2013	4992	0.150	Why?
Drug Evaluation	22	1991	432	0.150	Why?
Granulocyte Colony-Stimulating Factor	4	2011	770	0.150	Why?
Physical Examination	5	2006	306	0.150	Why?
Gene Expression Profiling	5	2011	5144	0.150	Why?
Stroke Volume	5	2013	550	0.150	Why?
Menopause	15	2001	156	0.140	Why?
Carcinoma, Lobular	5	2007	622	0.140	Why?
Peptichemio	5	1984	12	0.140	Why?
Multivariate Analysis	14	2009	4315	0.140	Why?
Antibodies, Anti-Idiotypic	2	1995	100	0.140	Why?
Signal Transduction	6	2016	12033	0.140	Why?
Quinolones	1	2018	163	0.140	Why?
Genes, erbB-2	2	2010	227	0.140	Why?
Incidence	14	2007	5814	0.140	Why?
Postoperative Care	6	2014	726	0.140	Why?
Risk	7	2016	1929	0.130	Why?
Practice Patterns, Physicians'	1	2005	1301	0.130	Why?
Probability	7	2005	886	0.130	Why?
Fluorine Radioisotopes	4	1997	140	0.130	Why?
Immunologic Factors	1	1999	669	0.130	Why?
Genetic Predisposition to Disease	2	2021	5776	0.120	Why?
Promethazine	1	1994	6	0.120	Why?
TOR Serine-Threonine Kinases	2	2013	1535	0.120	Why?
Lorazepam	1	1994	40	0.120	Why?
Inflammation	10	2007	2491	0.120	Why?
Heart	7	2002	1173	0.120	Why?
Preoperative Care	6	2008	1581	0.120	Why?
Confidence Intervals	6	2008	747	0.120	Why?
Administration, Oral	11	2010	1592	0.110	Why?
Antibodies, Neoplasm	2	1997	273	0.110	Why?
Bone Neoplasms	16	2007	2674	0.110	Why?
Drug Eruptions	3	1996	271	0.110	Why?
Carcinoma in Situ	3	2010	489	0.110	Why?
Carcinoembryonic Antigen	3	2000	232	0.110	Why?
Women's Health	3	2013	180	0.110	Why?
Odds Ratio	6	2016	2297	0.110	Why?
Therapeutic Equivalency	3	2002	49	0.110	Why?
Alkaloids	2	1991	85	0.110	Why?
Melphalan	4	1987	879	0.110	Why?
Overweight	1	2016	480	0.100	Why?
Genome-Wide Association Study	5	2021	2346	0.100	Why?
Nail Diseases	1	1993	39	0.100	Why?
Foot Diseases	1	1993	50	0.100	Why?
Blood Proteins	3	2010	297	0.100	Why?
Liver Neoplasms	12	2000	4839	0.100	Why?
Neoplasms	7	2017	15949	0.100	Why?
Genetic Association Studies	2	2017	1098	0.100	Why?
Patient Advocacy	1	1992	89	0.100	Why?
Vincristine	15	2001	1582	0.100	Why?
Oligonucleotides	2	2011	239	0.100	Why?
Tumor Suppressor Proteins	1	2020	1901	0.100	Why?
Tomography, Emission-Computed	4	1997	334	0.100	Why?
Analysis of Variance	9	2009	2313	0.100	Why?
Cognition Disorders	2	2010	762	0.100	Why?
Triple Negative Breast Neoplasms	1	2022	1385	0.100	Why?
Random Allocation	14	1990	727	0.100	Why?
Predictive Value of Tests	12	2007	4963	0.090	Why?
Regression Analysis	8	2014	1562	0.090	Why?
Clinical Trials, Phase III as Topic	4	2004	503	0.090	Why?
Cohort Studies	10	2016	9450	0.090	Why?
Safety	2	2005	457	0.090	Why?
Body Mass Index	5	2016	2225	0.090	Why?
Bone Marrow Transplantation	5	2000	1754	0.090	Why?
North America	2	2002	337	0.090	Why?
Prednisone	11	2001	1034	0.090	Why?
Hormones	6	2005	284	0.090	Why?
Bevacizumab	2	2012	967	0.090	Why?
Mitoxantrone	7	1999	227	0.090	Why?
Androstenedione	3	2014	18	0.090	Why?
Computer Simulation	1	2006	1567	0.090	Why?
Dexamethasone	2	2000	1525	0.090	Why?
Albumin-Bound Paclitaxel	1	2010	9	0.090	Why?
Ellipticines	1	1990	2	0.090	Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	1	2010	206	0.090	Why?
Gene Expression Regulation, Enzymologic	1	2013	690	0.090	Why?
Treatment Failure	4	2007	1429	0.090	Why?
Antineoplastic Agents, Alkylating	4	2008	605	0.090	Why?
Hematinics	1	2011	108	0.080	Why?
Membrane Proteins	1	2020	2922	0.080	Why?
Mitogen-Activated Protein Kinases	2	2004	667	0.080	Why?
Urokinase-Type Plasminogen Activator	1	1990	136	0.080	Why?
Vena Cava, Superior	1	1990	77	0.080	Why?
Biomedical Research	1	2016	799	0.080	Why?
Neutropenia	6	2002	1006	0.080	Why?
Radiotherapy, Adjuvant	8	2014	2272	0.080	Why?
Immunotherapy	7	1999	3561	0.080	Why?
Leukopenia	6	1985	152	0.080	Why?
CA-125 Antigen	1	2000	229	0.080	Why?
Drug Hypersensitivity	2	1990	135	0.080	Why?
Young Adult	9	2015	22238	0.080	Why?
Neoplasm Grading	1	2013	1828	0.080	Why?
Hematopoietic Stem Cell Transplantation	7	2006	7055	0.080	Why?
Infusions, Intravenous	10	2010	1436	0.080	Why?
Biopsy, Needle	5	2004	1381	0.080	Why?
Oligonucleotide Array Sequence Analysis	2	2006	2477	0.080	Why?
Survival	2	2013	183	0.080	Why?
HSP90 Heat-Shock Proteins	1	2009	191	0.080	Why?
Tumor Suppressor Protein p53	3	2006	3656	0.080	Why?
Etoposide	7	2006	907	0.080	Why?
Albumins	1	2010	263	0.080	Why?
Ultrasonography, Mammary	3	2006	387	0.080	Why?
Estrogen Receptor alpha	2	2020	691	0.080	Why?
SEER Program	4	2008	1051	0.080	Why?
Nuclear Proteins	2	2013	3435	0.070	Why?
Collagen Type IV	1	2008	106	0.070	Why?
Thrombolytic Therapy	1	1990	250	0.070	Why?
Research Design	4	2017	1559	0.070	Why?
Antineoplastic Agents, Immunological	1	2017	1337	0.070	Why?
Radiation-Sensitizing Agents	1	1990	368	0.070	Why?
Premedication	3	2004	132	0.070	Why?
Endpoint Determination	2	2012	179	0.070	Why?
Protein Kinase Inhibitors	2	2016	4965	0.070	Why?
Drug Approval	2	2012	173	0.070	Why?
Animals	11	2013	61340	0.070	Why?
Central Nervous System Neoplasms	2	2004	551	0.070	Why?
Neoplasms, Multiple Primary	2	1988	557	0.070	Why?
In Situ Hybridization, Fluorescence	2	2016	2312	0.070	Why?
Peripheral Nervous System Diseases	3	2009	407	0.070	Why?
Immunosuppressive Agents	1	1994	1436	0.070	Why?
Drug Interactions	3	2008	572	0.070	Why?
Europe	3	2001	649	0.070	Why?
Gene Expression	1	2015	3606	0.070	Why?
Quality of Health Care	1	2011	614	0.070	Why?
Actuarial Analysis	2	2001	170	0.070	Why?
Male	34	2011	128446	0.070	Why?
Drug Evaluation, Preclinical	1	2008	492	0.070	Why?
Carcinoma, Ductal	2	2005	144	0.070	Why?
Catheterization, Central Venous	1	1990	363	0.070	Why?
Thalidomide	1	2000	597	0.070	Why?
Lipids	2	2003	651	0.070	Why?
Recurrence	6	2009	4878	0.070	Why?
Lymph Node Excision	6	2000	2068	0.070	Why?
Aminoacridines	3	1986	23	0.070	Why?
CD40 Antigens	1	2007	107	0.070	Why?
Neuralgia	1	2009	265	0.070	Why?
Tissue Array Analysis	1	2008	757	0.070	Why?
Receptors, Steroid	1	2007	337	0.070	Why?
Heart Diseases	4	1999	722	0.070	Why?
Neoplasm Proteins	5	2021	3345	0.070	Why?
Quality of Life	6	2015	4806	0.060	Why?
Food-Drug Interactions	1	2005	20	0.060	Why?
Thrombocytopenia	8	1991	871	0.060	Why?
Cross-Over Studies	2	2004	455	0.060	Why?
Gonadal Steroid Hormones	1	2006	112	0.060	Why?
Tissue Fixation	1	2006	137	0.060	Why?
Formaldehyde	1	2006	115	0.060	Why?
Genotype	4	2019	4245	0.060	Why?
Patient Care Management	1	2006	92	0.060	Why?
Protein Kinases	1	2009	889	0.060	Why?
Paraffin Embedding	1	2006	223	0.060	Why?
RNA, Neoplasm	2	2003	805	0.060	Why?
Fever	3	2002	516	0.060	Why?
Texas	6	2007	6445	0.060	Why?
Blood Specimen Collection	1	2005	96	0.060	Why?
Nanoparticles	1	2010	584	0.060	Why?
Anemia	1	2011	725	0.060	Why?
Organoplatinum Compounds	1	1987	707	0.060	Why?
Polyps	1	2005	81	0.060	Why?
Receptor Cross-Talk	1	2005	78	0.060	Why?
Thrombosis	2	1992	742	0.060	Why?
Controlled Clinical Trials as Topic	1	2004	32	0.060	Why?
Estrogen Receptor beta	1	2005	149	0.060	Why?
Pregnancy, High-Risk	1	2004	48	0.060	Why?
Chromatography, High Pressure Liquid	1	2005	590	0.060	Why?
Cancer Vaccines	1	2009	754	0.060	Why?
Mucin-1	1	2004	158	0.060	Why?
Area Under Curve	1	2005	731	0.060	Why?
Drug Resistance	7	1999	608	0.060	Why?
Data Interpretation, Statistical	1	2006	481	0.060	Why?
Health Care Costs	2	2011	696	0.060	Why?
Celecoxib	1	2004	198	0.060	Why?
Health Care Surveys	1	2005	415	0.050	Why?
Nomograms	1	2005	312	0.050	Why?
Diagnosis, Differential	7	2000	4837	0.050	Why?
Radionuclide Imaging	3	2000	654	0.050	Why?
Myelodysplastic Syndromes	1	2016	3155	0.050	Why?
Health Services	1	2003	100	0.050	Why?
Uterus	2	2005	799	0.050	Why?
Disease Management	2	2006	1092	0.050	Why?
Mass Spectrometry	1	2005	721	0.050	Why?
Cisplatin	8	2006	2508	0.050	Why?
Radiotherapy Dosage	7	2014	4020	0.050	Why?
Pigmentation Disorders	2	1979	42	0.050	Why?
Mammary Neoplasms, Experimental	2	1998	551	0.050	Why?
National Cancer Institute (U.S.)	2	2017	219	0.050	Why?
Quality-Adjusted Life Years	1	2003	239	0.050	Why?
Acanthosis Nigricans	1	1992	15	0.050	Why?
Cholesterol, LDL	1	2006	577	0.050	Why?
Radiography	3	2004	1994	0.050	Why?
Gene Expression Regulation, Neoplastic	5	2013	9048	0.050	Why?
Transplantation, Autologous	7	2006	2073	0.050	Why?
Reproducibility of Results	4	2006	6192	0.050	Why?
Clinical Trials, Phase I as Topic	1	2005	626	0.050	Why?
Paraneoplastic Syndromes	1	1992	82	0.050	Why?
Cytochrome P-450 Enzyme System	1	2003	209	0.050	Why?
Endometrial Neoplasms	3	2005	1386	0.050	Why?
Leucovorin	4	1997	345	0.050	Why?
Consensus	1	2006	1113	0.050	Why?
Colitis	1	2004	340	0.050	Why?
Genetic Testing	1	2010	1692	0.050	Why?
Education, Medical, Continuing	1	2003	230	0.050	Why?
Metaplasia	1	2022	387	0.050	Why?
Neuregulin-1	1	2001	89	0.050	Why?
Radiotherapy, High-Energy	2	1981	303	0.050	Why?
Genome, Human	2	2021	1896	0.050	Why?
Remission, Spontaneous	12	1980	125	0.040	Why?
Headache	1	2001	172	0.040	Why?
Severity of Illness Index	3	2003	4391	0.040	Why?
Sensitivity and Specificity	6	2006	5157	0.040	Why?
Breast Self-Examination	1	2000	17	0.040	Why?
Logistic Models	4	2009	3423	0.040	Why?
Chemoprevention	1	2001	251	0.040	Why?
Sentinel Lymph Node Biopsy	2	2014	1464	0.040	Why?
Mastectomy, Modified Radical	5	2007	75	0.040	Why?
Tongue Diseases	1	1979	19	0.040	Why?
Genes, p53	1	2004	1140	0.040	Why?
Adolescent	13	2011	32687	0.040	Why?
Oropharynx	1	1979	81	0.040	Why?
Reverse Transcriptase Polymerase Chain Reaction	1	2006	3582	0.040	Why?
Smallpox Vaccine	1	1979	35	0.040	Why?
Cost-Benefit Analysis	1	2003	965	0.040	Why?
Neoplasms, Unknown Primary	1	2001	199	0.040	Why?
Transcription Factors	1	2013	5415	0.040	Why?
Enterocolitis, Pseudomembranous	1	2000	109	0.040	Why?
Rats	4	2005	6396	0.040	Why?
Pneumonia	2	2004	791	0.040	Why?
Pharmacogenetics	1	2020	267	0.040	Why?
Cricetinae	2	1998	744	0.040	Why?
Leukemia, Lymphoid	1	1979	289	0.040	Why?
Reference Values	3	2006	1127	0.040	Why?
Carcinoma, Papillary	1	1992	566	0.040	Why?
Registries	3	2016	2208	0.040	Why?
Pulmonary Fibrosis	1	1980	175	0.040	Why?
Chromosomes, Human, Pair 2	1	2019	188	0.040	Why?
Models, Biological	3	2004	3186	0.040	Why?
MicroRNAs	1	2011	2882	0.040	Why?
GPI-Linked Proteins	1	2019	233	0.040	Why?
Ifosfamide	1	1979	358	0.040	Why?
Medical Records	3	2008	441	0.040	Why?
Drug Resistance, Multiple	1	1999	221	0.040	Why?
RNA, Messenger	3	2015	6344	0.040	Why?
Paraplegia	1	1978	99	0.040	Why?
Antigens, Tumor-Associated, Carbohydrate	1	1997	120	0.040	Why?
Medroxyprogesterone	2	1989	13	0.040	Why?
Mastectomy, Simple	3	1993	59	0.040	Why?
Immunohistochemistry	4	2013	7646	0.040	Why?
Chromosomes, Human, Pair 16	1	2019	257	0.040	Why?
Heart Function Tests	1	1997	72	0.040	Why?
Hematologic Diseases	3	1990	255	0.040	Why?
Practice Guidelines as Topic	1	2007	2395	0.040	Why?
Interferon-alpha	2	1992	958	0.040	Why?
Pregnanes	1	1997	4	0.040	Why?
Diethylstilbestrol	1	1977	165	0.040	Why?
Liver Diseases	2	1983	600	0.040	Why?
Colorectal Neoplasms	2	2000	3707	0.040	Why?
Carcinoma, Hepatocellular	1	2000	2191	0.040	Why?
Testosterone	2	2014	638	0.040	Why?
DNA Adducts	1	1998	214	0.040	Why?
Immunoenzyme Techniques	4	2004	1188	0.030	Why?
INDEL Mutation	1	2017	114	0.030	Why?
Granuloma	1	1978	151	0.030	Why?
Insulin Resistance	1	1992	718	0.030	Why?
Leukemia, Myeloid, Acute	1	2016	7273	0.030	Why?
Clinical Trials, Phase II as Topic	2	2002	694	0.030	Why?
Ovariectomy	1	1998	370	0.030	Why?
Tumor Burden	2	2017	2033	0.030	Why?
Erythema Multiforme	1	1996	13	0.030	Why?
Castration	6	1983	122	0.030	Why?
Raloxifene Hydrochloride	2	2005	46	0.030	Why?
Antibody Formation	2	1995	378	0.030	Why?
Ultrasonography	5	2001	1931	0.030	Why?
Cell Proliferation	2	2006	7232	0.030	Why?
Mediastinal Neoplasms	1	2000	428	0.030	Why?
Biopsy, Fine-Needle	2	2011	690	0.030	Why?
Deoxyglucose	1	1996	119	0.030	Why?
Hyperbilirubinemia	1	1996	78	0.030	Why?
Cause of Death	2	2005	780	0.030	Why?
Up-Regulation	2	2007	2412	0.030	Why?
Tegafur	3	1988	51	0.030	Why?
Myocardial Infarction	1	2003	1154	0.030	Why?
Clavicle	2	2001	68	0.030	Why?
Bridged-Ring Compounds	2	2007	194	0.030	Why?
9,10-Dimethyl-1,2-benzanthracene	2	2005	128	0.030	Why?
Patient Care Planning	2	2011	300	0.030	Why?
Tissue Distribution	4	2005	920	0.030	Why?
Proto-Oncogene Proteins	1	2004	2618	0.030	Why?
Statistics, Nonparametric	3	2006	982	0.030	Why?
Pyrazoles	1	2004	1550	0.030	Why?
Blood Cell Count	8	1996	233	0.030	Why?
Lung Neoplasms	5	2002	12036	0.030	Why?
Brain Diseases	1	1978	411	0.030	Why?
Polymerase Chain Reaction	2	2011	3463	0.030	Why?
Sulfonamides	1	2004	1942	0.030	Why?
Bacterial Vaccines	2	1987	100	0.030	Why?
Pregnancy	4	2004	7916	0.030	Why?
Comorbidity	2	2011	2393	0.030	Why?
Cell Line, Tumor	4	2009	14878	0.030	Why?
Evaluation Studies as Topic	5	1997	449	0.030	Why?
Leukemia	4	1996	1719	0.030	Why?
Alopecia	5	1986	125	0.030	Why?
Radiation Injuries	3	2006	1476	0.030	Why?
Neuropsychological Tests	2	2010	1145	0.030	Why?
Paronychia	1	1993	4	0.030	Why?
Rats, Sprague-Dawley	3	2005	2139	0.030	Why?
Nucleotide Motifs	1	2013	61	0.030	Why?
Information Systems	3	1987	51	0.030	Why?
Toes	1	1993	49	0.030	Why?
Soft Tissue Neoplasms	6	2007	930	0.030	Why?
Protein Binding	2	2013	3472	0.030	Why?
Liver Function Tests	3	1988	184	0.030	Why?
Liability, Legal	1	1992	45	0.030	Why?
Algorithms	3	2011	3903	0.030	Why?
Species Specificity	1	1994	783	0.030	Why?
Sleep Stages	2	1982	82	0.030	Why?
Radiotherapy	2	2014	1858	0.030	Why?
Fingers	1	1993	130	0.030	Why?
Biomarkers	1	2004	5048	0.030	Why?
Phenotype	2	2017	6502	0.020	Why?
Insulin-Like Growth Factor Binding Protein 1	1	2011	30	0.020	Why?
Cardiomyopathies	2	1989	548	0.020	Why?
Iodine Radioisotopes	1	1994	388	0.020	Why?
Thiotepa	3	1990	132	0.020	Why?
Chromatin Immunoprecipitation	1	2013	506	0.020	Why?
Chromosomes, Human, Pair 8	1	2013	329	0.020	Why?
Germ-Line Mutation	1	2017	1101	0.020	Why?
Chi-Square Distribution	2	2007	1306	0.020	Why?
Clinical Protocols	1	1994	476	0.020	Why?
MCF-7 Cells	1	2013	547	0.020	Why?
Apoptosis	1	2006	7755	0.020	Why?
Population Surveillance	1	2005	631	0.020	Why?
Insulin-Like Growth Factor Binding Protein 3	1	2011	155	0.020	Why?
Postoperative Period	1	1993	666	0.020	Why?
Autoradiography	2	2005	153	0.020	Why?
Thyroid Neoplasms	1	1992	1908	0.020	Why?
Levamisole	3	1979	13	0.020	Why?
Pain	2	1991	1701	0.020	Why?
Palliative Care	4	2002	2176	0.020	Why?
United States Food and Drug Administration	1	2012	322	0.020	Why?
p38 Mitogen-Activated Protein Kinases	2	2004	344	0.020	Why?
Fractures, Bone	3	2008	310	0.020	Why?
Antibody-Dependent Cell Cytotoxicity	1	2010	88	0.020	Why?
Neoplasm Regression, Spontaneous	2	1982	39	0.020	Why?
Canada	1	2001	441	0.020	Why?
Feasibility Studies	3	2001	2360	0.020	Why?
Mice	4	2005	35414	0.020	Why?
DNA Copy Number Variations	1	2017	1576	0.020	Why?
Pseudomonas	2	1987	22	0.020	Why?
Hypercalcemia	3	1996	146	0.020	Why?
Ethinyl Estradiol	1	1989	15	0.020	Why?
Bone Marrow	7	1984	2440	0.020	Why?
Electrophoretic Mobility Shift Assay	1	2010	201	0.020	Why?
Liver	3	2005	3057	0.020	Why?
Benchmarking	1	2011	276	0.020	Why?
Preoperative Period	1	2010	348	0.020	Why?
Databases, Factual	1	2016	2258	0.020	Why?
Chromatography, Liquid	1	2010	352	0.020	Why?
Skin Diseases	2	1982	371	0.020	Why?
Mastectomy, Radical	2	2004	40	0.020	Why?
Erythrocyte Transfusion	1	2011	207	0.020	Why?
Dihydrotestosterone	1	1989	94	0.020	Why?
Catheters, Indwelling	1	1992	382	0.020	Why?
alpha-Fetoproteins	1	2000	255	0.020	Why?
Agranulocytosis	4	1994	83	0.020	Why?
Insulin-Like Growth Factor I	1	2011	616	0.020	Why?
Anthraquinones	2	1985	28	0.020	Why?
Interferons	2	1980	297	0.020	Why?
Amenorrhea	3	1990	30	0.020	Why?
Recombinant Fusion Proteins	1	1994	1623	0.020	Why?
Ovary	2	2005	686	0.020	Why?
Carboplatin	1	2011	889	0.020	Why?
Bronchial Neoplasms	2	1978	82	0.020	Why?
Osteolysis	1	1988	99	0.020	Why?
Meta-Analysis as Topic	1	1988	271	0.020	Why?
Likelihood Functions	1	2008	240	0.020	Why?
Precision Medicine	1	2016	1216	0.020	Why?
Drug-Related Side Effects and Adverse Reactions	1	2012	626	0.020	Why?
Age of Onset	2	2001	853	0.020	Why?
Case-Control Studies	2	2013	6231	0.020	Why?
Arthralgia	1	2008	97	0.020	Why?
Secondary Prevention	1	2009	311	0.020	Why?
Glycoproteins	1	1991	775	0.020	Why?
Staphylococcal Protein A	1	1987	16	0.020	Why?
Hydrocortisone	1	1989	401	0.020	Why?
Arthritis	1	2008	148	0.020	Why?
Environment, Controlled	1	1987	22	0.020	Why?
Methylcellulose	1	1986	10	0.020	Why?
Interferon Inducers	1	1986	10	0.020	Why?
Polylysine	1	1986	19	0.020	Why?
Placebos	1	2008	438	0.020	Why?
Osteoradionecrosis	1	1988	128	0.020	Why?
Poly I-C	1	1986	31	0.020	Why?
Carboxymethylcellulose Sodium	1	1986	20	0.020	Why?
Amsacrine	2	1986	63	0.020	Why?
Patient Education as Topic	1	2011	745	0.020	Why?
Memory	1	2010	444	0.020	Why?
Blood	1	1987	162	0.020	Why?
Analgesics	1	2009	406	0.020	Why?
Base Sequence	1	2013	5405	0.020	Why?
Acute Disease	2	1990	2491	0.020	Why?
Methods	2	1990	221	0.020	Why?
Reoperation	1	2011	1388	0.020	Why?
Anthracenes	2	1986	47	0.020	Why?
Bleomycin	1	1987	482	0.020	Why?
Phosphonoacetic Acid	1	1985	19	0.020	Why?
Decision Making, Computer-Assisted	1	2005	33	0.020	Why?
Congresses as Topic	1	2008	300	0.020	Why?
France	1	2005	116	0.020	Why?
Carbon Radioisotopes	1	2005	124	0.020	Why?
Promoter Regions, Genetic	1	2013	3205	0.020	Why?
Molecular Sequence Data	1	2013	6638	0.020	Why?
Body Weight	2	2008	1282	0.020	Why?
Pyrrolidines	1	1986	112	0.020	Why?
Organophosphorus Compounds	1	1985	90	0.020	Why?
Electrocardiography	2	1983	1144	0.020	Why?
In Situ Nick-End Labeling	1	2006	437	0.020	Why?
Vinca Alkaloids	1	1985	8	0.020	Why?
Microarray Analysis	1	2006	396	0.020	Why?
Health Services Accessibility	1	2011	819	0.020	Why?
Aspartic Acid	1	1985	136	0.020	Why?
Hemorrhage	3	2001	724	0.020	Why?
Breast Diseases	1	1986	200	0.020	Why?
Nipples	1	2005	122	0.020	Why?
Molecular Targeted Therapy	1	2015	2396	0.010	Why?
Phlebitis	1	1984	9	0.010	Why?
Models, Chemical	1	2005	177	0.010	Why?
Flow Cytometry	1	2011	3040	0.010	Why?
Membrane Glycoproteins	1	1989	1091	0.010	Why?
Patient Acceptance of Health Care	1	2009	600	0.010	Why?
Mitomycin	1	1985	216	0.010	Why?
Half-Life	1	2004	268	0.010	Why?
Colonic Neoplasms	1	1992	1435	0.010	Why?
Bone Marrow Diseases	2	1984	186	0.010	Why?
Patient Compliance	1	1988	677	0.010	Why?
Luciferases	1	2005	454	0.010	Why?
Kinetics	1	2007	2206	0.010	Why?
Zinc Fingers	1	2004	220	0.010	Why?
Carcinogens	1	2005	390	0.010	Why?
Climacteric	1	2003	3	0.010	Why?
Paralysis	1	1983	54	0.010	Why?
Skin Neoplasms	1	2000	4892	0.010	Why?
DNA	1	2011	3041	0.010	Why?
Skull Neoplasms	1	1983	68	0.010	Why?
ROC Curve	1	2006	1250	0.010	Why?
Dizziness	1	1982	42	0.010	Why?
Age Distribution	1	2004	726	0.010	Why?
Genes, Reporter	1	2005	813	0.010	Why?
Cranial Nerve Diseases	1	1983	76	0.010	Why?
Surveys and Questionnaires	1	2015	5916	0.010	Why?
Patient Care Team	1	2008	824	0.010	Why?
Biopsy	2	2000	3490	0.010	Why?
Statistics as Topic	1	2003	448	0.010	Why?
Neoplasms, Experimental	1	2005	784	0.010	Why?
Hemangiosarcoma	1	1984	238	0.010	Why?
Neoplasms, Radiation-Induced	1	1984	402	0.010	Why?
Neoplasm Transplantation	1	2005	1553	0.010	Why?
Cobalt Radioisotopes	1	1981	41	0.010	Why?
Asparaginase	2	1980	196	0.010	Why?
Internet	1	2005	687	0.010	Why?
Radiation Tolerance	1	2004	639	0.010	Why?
Proto-Oncogene Proteins c-mdm2	1	2004	525	0.010	Why?
Edema	1	1982	264	0.010	Why?
Transcriptional Activation	1	2005	1107	0.010	Why?
Skin Tests	1	1981	100	0.010	Why?
Colonoscopy	1	2004	524	0.010	Why?
Thromboembolism	1	2001	150	0.010	Why?
Ranitidine	1	2000	42	0.010	Why?
Pregnancy Outcome	1	2004	639	0.010	Why?
Immune Complex Diseases	1	1980	12	0.010	Why?
Genes, BRCA2	1	2002	322	0.010	Why?
Altretamine	1	1979	4	0.010	Why?
Adrenal Cortex Hormones	2	1983	562	0.010	Why?
Nitrogen Mustard Compounds	1	1980	74	0.010	Why?
Radiation Dosage	1	2004	1042	0.010	Why?
Carrier Proteins	1	1998	2084	0.010	Why?
Electrons	1	1981	188	0.010	Why?
Pharyngeal Diseases	1	1979	51	0.010	Why?
Stomatitis	3	1989	190	0.010	Why?
Glomerulonephritis	1	1980	109	0.010	Why?
Frail Elderly	1	2000	124	0.010	Why?
Apgar Score	1	1999	51	0.010	Why?
Mouth Mucosa	1	1979	223	0.010	Why?
Cell Nucleus	1	2004	1715	0.010	Why?
Mucous Membrane	1	1979	258	0.010	Why?
Chlorambucil	1	1978	26	0.010	Why?
Triazines	1	1979	121	0.010	Why?
Urticaria	1	1978	28	0.010	Why?
Transcription, Genetic	1	2007	3328	0.010	Why?
Nitrosourea Compounds	1	1978	14	0.010	Why?
Bacterial Infections	3	1992	510	0.010	Why?
Disease	1	2000	165	0.010	Why?
Cytarabine	1	1985	2014	0.010	Why?
Nails	1	1978	37	0.010	Why?
Delphi Technique	1	2000	277	0.010	Why?
Lomustine	1	1978	42	0.010	Why?
Injections, Intraventricular	1	1978	124	0.010	Why?
Hypotension	2	1994	225	0.010	Why?
Azathioprine	1	1978	73	0.010	Why?
Daunorubicin	1	1979	313	0.010	Why?
Pituitary Gland	1	1978	151	0.010	Why?
Selection Bias	1	1997	47	0.010	Why?
Drug Carriers	1	1999	328	0.010	Why?
Medroxyprogesterone Acetate	2	1989	49	0.010	Why?
Mice, Nude	1	2005	4332	0.010	Why?
Birth Weight	1	1999	323	0.010	Why?
Amphotericin B	1	1978	301	0.010	Why?
Health Status	1	2000	625	0.010	Why?
Tomography, X-Ray Computed	2	2000	7786	0.010	Why?
Liposomes	1	1999	702	0.010	Why?
Leukemia, Radiation-Induced	1	1996	25	0.010	Why?
Minimally Invasive Surgical Procedures	1	2000	508	0.010	Why?
Parathyroid Hormone-Related Protein	1	1996	23	0.010	Why?
Life Tables	1	1996	118	0.010	Why?
Cross-Sectional Studies	1	2006	4493	0.010	Why?
Mouth Diseases	1	1996	38	0.010	Why?
Vaginal Diseases	1	1996	25	0.010	Why?
Complement C4	1	1995	14	0.010	Why?
Isoantigens	1	1995	66	0.010	Why?
Parathyroid Hormone	1	1996	183	0.010	Why?
Ventricular Function, Left	1	1999	563	0.010	Why?
Thoracic Neoplasms	1	1979	363	0.010	Why?
Complement C3	1	1995	80	0.010	Why?
Complement Activation	1	1995	86	0.010	Why?
Fetus	1	1999	670	0.010	Why?
Gestational Age	1	1999	1160	0.010	Why?
Syndrome	1	1978	1408	0.010	Why?
CD4-CD8 Ratio	1	1994	57	0.010	Why?
Infusions, Parenteral	2	1985	191	0.010	Why?
Vindesine	2	1985	11	0.010	Why?
Rats, Inbred F344	1	1994	235	0.010	Why?
Meningeal Neoplasms	1	1978	473	0.010	Why?
Pleural Effusion	3	1982	228	0.010	Why?
Magnesium	1	1994	170	0.010	Why?
Neuromuscular Diseases	1	1994	66	0.010	Why?
Vaccination	1	1979	1113	0.010	Why?
Longitudinal Studies	1	1998	2045	0.010	Why?
Decision Making	1	2000	1249	0.010	Why?
Leukocyte Count	2	1987	726	0.010	Why?
Tomography, Emission-Computed, Single-Photon	1	1994	333	0.010	Why?
Myocardium	1	1997	1180	0.010	Why?
Lymphoma	1	1980	1516	0.010	Why?
Indium Radioisotopes	1	1991	63	0.010	Why?
Muscular Diseases	1	1991	157	0.010	Why?
Pilot Projects	1	1997	2855	0.010	Why?
Nervous System Neoplasms	2	1980	35	0.010	Why?
Tritium	1	1990	266	0.010	Why?
Abortion, Incomplete	1	1990	7	0.010	Why?
Propionibacterium acnes	2	1980	25	0.010	Why?
Fluorodeoxyglucose F18	1	1996	1260	0.010	Why?
Pneumothorax	1	1992	166	0.010	Why?
Enzyme Induction	1	1990	257	0.010	Why?
False Negative Reactions	1	1990	291	0.010	Why?
Electrophoresis	1	1989	74	0.010	Why?
False Positive Reactions	1	1990	374	0.010	Why?
Blotting, Southern	1	1989	453	0.010	Why?
Postoperative Complications	1	1984	5674	0.000	Why?
Blotting, Northern	1	1989	719	0.000	Why?
Androgens	2	1983	506	0.000	Why?
Multiple Myeloma	1	1980	2336	0.000	Why?
Nucleic Acid Hybridization	1	1989	628	0.000	Why?
Vasopressins	1	1988	62	0.000	Why?
Proteins	1	1996	2030	0.000	Why?
Infusions, Intra-Arterial	1	1988	174	0.000	Why?
Peplomycin	1	1987	2	0.000	Why?
Sarcoma	1	1978	1851	0.000	Why?
Immunosorbent Techniques	1	1987	53	0.000	Why?
Sex Factors	1	1992	2180	0.000	Why?
Accidental Falls	1	1988	141	0.000	Why?
Granulocytes	1	1987	244	0.000	Why?
Aspartate Aminotransferases	1	1986	144	0.000	Why?
Tumor Cells, Cultured	1	1994	5759	0.000	Why?
Perfusion	1	1987	281	0.000	Why?
L-Lactate Dehydrogenase	1	1986	316	0.000	Why?
Spine	1	1986	312	0.000	Why?
Mitolactol	1	1984	7	0.000	Why?
Gastrointestinal Neoplasms	2	1980	629	0.000	Why?
DNA, Neoplasm	1	1989	1958	0.000	Why?
Blotting, Western	1	1989	3567	0.000	Why?
Blood Chemical Analysis	1	1983	112	0.000	Why?
Biometry	1	1984	251	0.000	Why?
Mutation	1	2002	15917	0.000	Why?
Cell Line	1	1989	5313	0.000	Why?
Lymphedema	1	1984	240	0.000	Why?
Bence Jones Protein	1	1980	11	0.000	Why?
Myeloma Proteins	1	1980	27	0.000	Why?
Breast	1	1987	1370	0.000	Why?
Respiratory Tract Neoplasms	1	1980	40	0.000	Why?
Global Health	1	1985	672	0.000	Why?
Injections, Intravenous	1	1981	590	0.000	Why?
Gastrointestinal Diseases	1	1985	616	0.000	Why?
Skin Ulcer	1	1980	76	0.000	Why?
Blood Pressure	1	1986	1555	0.000	Why?
Digestive System	1	1979	120	0.000	Why?
Urogenital Neoplasms	1	1980	118	0.000	Why?
Microscopy, Electron	1	1980	697	0.000	Why?
Platelet Count	1	1980	488	0.000	Why?
Drug Therapy	1	1979	205	0.000	Why?
Thyrotropin-Releasing Hormone	1	1978	16	0.000	Why?
Leukocytes	1	1980	420	0.000	Why?
Heart Neoplasms	1	1980	209	0.000	Why?
Luteinizing Hormone	1	1978	165	0.000	Why?
Cross Reactions	1	1978	255	0.000	Why?
Prolactin	1	1978	169	0.000	Why?
Follicle Stimulating Hormone	1	1978	224	0.000	Why?
Echocardiography	1	1983	1218	0.000	Why?
Central Nervous System	1	1979	450	0.000	Why?
Dacarbazine	1	1978	502	0.000	Why?
Diagnostic Errors	1	1980	517	0.000	Why?
Anti-Bacterial Agents	1	1987	3187	0.000	Why?
Brain Neoplasms	2	1979	4968	0.000	Why?
Infant	1	1984	13994	0.000	Why?
Prostatic Neoplasms	1	1985	5867	0.000	Why?
Child, Preschool	1	1984	17071	0.000	Why?
Child	1	1984	30558	0.000	Why?

BUZDAR's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (755)

Explore

Co-Authors (108)

Explore

Similar People (60)

Explore

Same Department

Explore